ZNF528: A Protein with Potential as A Drug Target Or Biomarker
ZNF528: A Protein with Potential as A Drug Target Or Biomarker
ZNF528 (MGC138155) is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the ZNF family of proteins, which are known for their role in regulating gene expression and cell signaling. ZNF528 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, ZNF528 has generated a lot of interest as a potential drug target or biomarker.
One of the key features of ZNF528 is its ability to interact with other proteins. This interaction allows it to modulate the activity of these proteins, which can have a significant impact on cellular processes such as cell growth, differentiation, and survival. One of the most well-studied interactions of ZNF528 is its interaction with the protein p21 (TIM-3).
p21 is a tumor suppressor protein that is expressed in a variety of tissues, including the brain. It has been shown to play a role in preventing the formation of cancer cells, and is often targeted by oncogenic viruses and mutations. ZNF528 has been shown to interact with p21 and enhance its activity in preventing cancer cell formation. This interaction between ZNF528 and p21 has implications for the development of cancer therapies that target this pathway.
Another interaction of ZNF528 is its role in the regulation of cell apoptosis, or programmed cell death. Apoptosis is a natural process that helps remove damaged or dysfunctional cells from the body, and is an important part of the immune system's response to disease. However, in some diseases, cells do not properly apoptose, leading to the build-up of damaged or dysfunctional cells that can lead to chronic suffering. ZNF528 has been shown to regulate cell apoptosis and contribute to the proper disposal of damaged cells. This regulation is important for the development of therapeutic strategies for diseases such as neurodegenerative diseases and cancer.
In addition to its role in cell signaling, ZNF528 has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion. These processes are important for the development and progression of many diseases, including cancer. ZNF528 has been shown to regulate cell adhesion and migration, which are critical for the formation of cancer cells and the development of invasive tumors.
Given the complexity of its role in cellular processes, ZNF528 has a wide range of potential applications as a drug target or biomarker. For example, it could be used to develop therapies for cancer, neurodegenerative diseases, and autoimmune disorders. It could also be used to monitor the effectiveness of therapies and determine potential biomarkers for these diseases.
In conclusion, ZNF528 is a protein that has a wide range of potential applications as a drug target or biomarker. Its ability to interact with other proteins and regulate cellular processes such as cell signaling, apoptosis, and cell adhesion make it an attractive target for therapeutic development. Further research is needed to fully understand the role of ZNF528 in cellular processes and its potential as a therapeutic agent.
Protein Name: Zinc Finger Protein 528
Functions: May be involved in transcriptional regulation
The "ZNF528 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF528 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567 | ZNF568 | ZNF569 | ZNF56P | ZNF57 | ZNF570 | ZNF571 | ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618 | ZNF619 | ZNF620 | ZNF621 | ZNF622 | ZNF623 | ZNF624 | ZNF625 | ZNF625-ZNF20 | ZNF626 | ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639
